Method for efficiently expressing phospholipase D and application
By using signal peptides and promoter modification in Bacillus subtilis, the problem of low phospholipase D expression is solved, the enzyme activity and stability is improved, suitable for industrial production, and the antibiotics are reduced. use.
Patent Information
- Application Number
- CN202411100911.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-12
AI Technical Summary
In the prior art, the secretion expression level of phospholipase D is low, which is difficult to meet the needs of industrial applications. The use of antibiotics as screening pressure increases production costs and food safety risks.
Through signal peptide and promoter modification, free plasmids and integrated expression systems of phospholipase D are developed to achieve efficient secretion and expression of phospholipase D in Bacillus subtilis, reducing the dependence on antibiotics.
It significantly improves the enzyme activity of phospholipase D, and the extracellular enzyme activity reaches 815.9U/mL, reducing the use of organic solvents, has high stability, and is suitable for large-scale industrial production.
Smart Images

Figure CN118931874A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for efficiently expressing phospholipase D and application thereof, belonging to the technical field of genetic engineering. Background Art
[0002] Phospholipids, also known as phosphoglycerides, refer to lipids containing phosphoric acid, including phosphatidic acid (PA), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylinositol (PI), phosphatidylserine (PS), etc. They are important substances that make up the biological membrane in the body, and are also important components of poultry egg yolks, plant seeds, animal brains and internal organs, etc., and play an extremely important role in the life activities of organisms. Among them, phosphatidic acid is the simplest diacylglycerol phospholipid, one end of the fatty acid group has strong lipophilicity, and one end of the phosphate group has strong hydrophilicity. It is the synthetic precursor of glyceride and most phospholipids, and is also an important second messenger in the cell, acting as a signal lipid molecule. Phosphatidic acid has the effects of inhibiting bitterness, anti-depression, treating amputation, joint lubrication and promoting hair growth, so it has a wide range of application value in the fields of medicine, food, cosmetics, etc.
[0003] The methods for preparing phosphatidic acid mainly include solvent extraction, chemical synthesis and enzyme conversion. At present, solvent extraction is the most important method for producing phosphatidic acid, but the extraction process of this method is cumbersome, the separation efficiency is low, the cost is high, and various chemical organic solvents are required, which is easy to cause environmental pollution and is not suitable for industrial production. The chemical synthesis method has cumbersome steps, low overall yield and high production cost, and is not suitable for industrial production. The enzyme conversion method refers to the hydrolysis reaction of the substrate lecithin under the catalysis of phospholipase D with catalytic effect to synthesize phosphatidic acid. The enzyme conversion method has the advantages of mild reaction conditions, relatively rich sources of raw material soybean lecithin and low cost, and green reaction process. Therefore, the enzyme conversion method has gradually become an ideal method for synthesizing phosphatidic acid. At present, there are few reports on the preparation of phosphatidic acid using biocatalysis, and the highest reported yield is about 69g / L, the time-space yield is only 6.9g / L / h, and the use of a two-phase catalytic reaction system has a long reaction time and requires the use of organic solvents, which is not conducive to industrial production.
[0004] The study of high-yield phospholipase D started with the optimization of fermentation conditions for wild Streptomyces. However, due to the limitations of Streptomyces itself, such as long fermentation cycle and complex culture conditions, researchers began to seek methods for heterologous expression of phospholipase D by genetic engineering, and explored heterologous expression of the enzyme through hosts such as Bacillus subtilis, Pichia pastoris, Corynebacterium, and Escherichia coli. At present, high-level expression of phospholipase D has been achieved in Escherichia coli Top 10, with the highest enzyme activity of about 1100U / mL. However, Escherichia coli has endotoxins and requires post-processing steps such as cell disruption, which is not conducive to the large-scale industrial application of phospholipase D. Bacillus subtilis does not produce any endotoxins, is non-pathogenic, has simple fermentation, grows rapidly, and can efficiently secrete various proteins. It is an ideal host for phospholipase D expression. At present, phospholipase D has been heterologously expressed in Bacillus subtilis, and the enzyme activity of the recombinant strain can reach 149.7U / mL, but the secretion expression level of phospholipase D is still low, which is difficult to meet the needs of industrial application.
[0005] In the production process of industrial enzymes, antibiotics need to be added as screening pressure during the cultivation of recombinant strains based on free expression to avoid large-scale loss of recombinant plasmids during passage, so as to ensure the efficient production of target products and maintain the stability of recombinant plasmids. However, the use of antibiotics will not only increase the production cost of adding antibiotics during the fermentation preparation period of industrial enzymes, but also the antibiotics need to be further separated and removed during product purification after use, which also increases the difficulty and production cost of downstream separation and purification. More importantly, the addition of antibiotics will bring food safety risks and does not meet the requirements of industrial enzymes in industries such as food. Integrated expression is the integration of exogenous genes into the chromosomes of the expression host, which can achieve stable expression of the target protein and avoid the use of antibiotics. However, the expression level of integrated expression is generally low, and there is no report on the integrated expression of phospholipase D in Bacillus subtilis. Therefore, the development of an efficient integrated expression system for phospholipase D is helpful for the industrial application of phospholipase D. Summary of the invention
[0006] In order to solve the above technical problems, the present invention provides a method and application of efficiently expressing phospholipase D, realizes efficient secretory expression of phospholipase D through signal peptide and promoter modification, provides a free plasmid including phospholipase D gene and a recombinant strain containing the plasmid; the present invention develops a method of integrated expression of phospholipase D based on free expression, realizes integrated expression of phospholipase D in Bacillus subtilis; at the same time, the present invention provides a method of producing phosphatidic acid using recombinant strains and integrated strains. The current problem of low secretory expression level of phospholipase D is solved, and the application range of phospholipase D in industry is expanded.
[0007] The first object of the present invention is to provide a phospholipase D gene expression cassette, which comprises a signal peptide penP coding sequence, a promoter P43 coding sequence and a phospholipase D gene coding sequence regulated by the signal peptide penP and the promoter P43.
[0008] Furthermore, the nucleotide sequence of the signal peptide penP is shown as SEQ ID NO.1.
[0009] Furthermore, the nucleotide sequence of the promoter P43 is shown in SEQ ID NO.2.
[0010] Furthermore, the amino acid sequence of the phospholipase D is shown in SEQ ID NO.11.
[0011] Furthermore, the phospholipase gene expression cassette nucleotide sequence is shown in SEQ ID NO.3.
[0012] The second object of the present invention is to provide an episomal plasmid for expressing phospholipase D, wherein the episomal plasmid comprises the above-mentioned phospholipase D gene expression cassette.
[0013] Furthermore, the episomal plasmid uses pMA5 as a vector to express phospholipase D, and the nucleotide sequence of the episomal plasmid is shown in SEQ ID NO.10.
[0014] The third object of the present invention is to provide a recombinant strain expressing phospholipase D in a free manner, wherein the recombinant strain uses Bacillus subtilis as a host and the above-mentioned free plasmid is introduced into the host.
[0015] Furthermore, the Bacillus subtilis is Bacillus subtilis WB600.
[0016] The fourth object of the present invention is to provide an integrated strain for expression of phospholipase D, wherein the integrated strain uses Bacillus subtilis as a host, and the above-mentioned phospholipase D gene expression cassette is integrated into the host genome.
[0017] Furthermore, the gene sites integrated into the host genome include one or more of veg, amyE and zinU genes.
[0018] Furthermore, the sequence of the upstream homology arm of the gene veg is shown as SEQ ID NO.4, and the sequence of the downstream homology arm is shown as SEQ ID NO.5.
[0019] Furthermore, the sequence of the upstream homology arm of the gene amyE is shown as SEQ ID NO.6, and the sequence of the downstream homology arm is shown as SEQ ID NO.7.
[0020] Furthermore, the sequence of the upstream homology arm of the gene zinU is shown as SEQ ID NO.8, and the sequence of the downstream homology arm is shown as SEQ ID NO.9.
[0021] Furthermore, the Bacillus subtilis is Bacillus subtilis WB600.
[0022] The fourth object of the present invention is to provide the use of the above-mentioned recombinant strain or integrated strain in the fermentation production of phospholipase D, and the specific fermentation steps are as follows:
[0023] The seed liquid is inoculated into the fermentation medium at an inoculation rate of 5-10%, the pH is controlled at 7-7.5, the ventilation volume is 1-2vvm, the culture temperature is 35-38°C, and the dissolved oxygen is controlled at 20-40%; and after fermentation for 15-20 hours, feed culture medium is added according to the dissolved oxygen flow.
[0024] Furthermore, the fermentation medium contains 5-10 g / L of glycerol, 10-20 g / L of peptone, 15-25 g / L of soybean cake extract powder, 2-3 g / L of potassium dihydrogen phosphate and 15-20 g / L of dipotassium hydrogen phosphate trihydrate.
[0025] Furthermore, the seed solution is obtained by inoculating the strain into a TB liquid culture medium and culturing the strain at a temperature of 35-38° C. and a rotation speed of 200-220 rpm until the logarithmic growth phase.
[0026] Furthermore, the feed medium is fed according to the dissolved oxygen. When the dissolved oxygen exceeds 30%, the feeding of the feed medium is started, and when the dissolved oxygen is lower than 30%, the feeding of the feed medium is stopped.
[0027] A fifth object of the present invention is to provide an application of the above-mentioned recombinant strain or integrated strain in the production of phosphatidic acid, wherein the application is:
[0028] The recombinant strain or the integrated strain is used to ferment and produce phospholipase D, and the phospholipase D is used as a catalyst to catalyze soybean lecithin to generate phosphatidic acid.
[0029] Furthermore, the catalytic system is an aqueous phase catalytic system.
[0030] Furthermore, the amount of soybean lecithin added is 50-300 g / L.
[0031] Furthermore, the catalysis is carried out at 25-55° C. for 1-10 hours.
[0032] The beneficial effects of the present invention are:
[0033] The present invention optimizes expression elements through system transformation, constructs free plasmids and recombinant strains, realizes efficient secretory expression of phospholipase D, and the extracellular enzyme activity reaches 815.9U / mL, which is 8.7 times higher than that of unmodified strains, and the enzyme activity on the tank is increased to 4055.9U / mL. The present invention also successfully realizes efficient integrated expression of phospholipase D based on this free expression system, and the extracellular enzyme activity reaches 392.9U / mL, realizing the integrated expression of phospholipase D for the first time. The phospholipase D of the present invention has good catalytic ability, can synthesize phosphatidic acid with lecithin as substrate, and the phosphatidic acid yield reaches 219.1g / L, and the use of organic solvents is significantly reduced. The recombinant strain has good enzyme activity stability, short fermentation cycle, and high phosphatidic acid yield, which lays the foundation for large-scale industrial production and has potential application value in the field of biosynthesis of phosphatidic acid. At the same time, the integrated strain avoids the addition of antibiotics during the fermentation process, broadening the application range of the strain. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 This is the pPLDsan31 plasmid map.
[0035] Figure 2 It is a schematic diagram of the integration expression strain BS-PLD312.
[0036] Figure 3 This is the SDS-PAGE profile of phospholipase D under expression element modification and high-density fermentation strategy. Lane M: protein marker; Lane 1: protein band of control BS-pMA5; Lane 2: protein band of strain BS-pPLDsan; Lane 3: protein band of strain BS-pPLDsan31; Lane 4: protein band of high-density fermentation of strain BS-pPLDsan31.
[0037] Figure 4 It is the enzyme activity test result of integrated expression of phospholipase D.
[0038] Figure 5 This is the fermentation enzyme activity curve of the recombinant strain BS-pPLDsan317-L in the tank.
[0039] Figure 6 This is the fermentation enzyme activity curve of the integrated strain BS-PLD3127-L tank.
[0040] Figure 7 It is the result of biocatalytic production of phosphatidic acid. DETAILED DESCRIPTION
[0041] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0042] The PLD enzyme activity detection method has the following specific steps:
[0043] The prepared 60 μL substrate lecithin solution (10 mg / mL lecithin, 0.1% (v / v) Triton X-100, 15 mM CaCl2 and 40 mM Tris-HCl (pH 7.5)) and 40 μL phospholipase D enzyme solution were fully mixed, and the reaction was oscillated on an oscillating constant temperature mixer at 60°C for 20 min, and 50 μL of reaction stop solution was added to stop the reaction, and the reaction was placed on ice after 5 min of boiling water bath; the reaction was centrifuged at 6000 rpm for 5 min, and all the supernatants (about 150 μL) were taken and added to 60 μL choline oxidase, 200 μL phenol solution, 200 μL 4-aminoantipyrine solution and 40 μL peroxidase, and the reaction was carried out in a 37°C constant temperature metal bath for 20 min; after the reaction was completed, the absorbance of the reaction solution was measured at 505 nm, and the enzyme activity was calculated according to the standard curve.
[0044] Enzyme activity is defined as the amount of enzyme solution used to catalyze 1 μmol of choline per minute, which is one unit of enzyme activity (U / mL).
[0045] The sequence involved in the present invention is as follows:
[0046] SEQ ID NO.1 Signal peptide penP
[0047] ATGAAGTTGAAAACTAAAGCGTCAATAAAATTCGGAATATGTGTT
[0048] GGGCTTTTATGTTTAAGCATTACTGGTTTCACAACCTTTTTTCAACTCAA
[0049] CACATGCCGAAGCA
[0050] SEQ ID NO.2 Promoter P43
[0051] TGATAGGTGGTATGTTTTCGCTTGAACTTTTAAATACAGCCATTGA
[0052] ACATACGGTTGATTTAATAACTGACAAACATCACCCTCTTGCTAAAGCG
[0053] GCCAAGGACCGCCGCCGCCGGGGCTGTTTGCGTTCTTGCCGTGATTTCG
[0054] TGTACCATTGGTTTACTTATTTTTTTGCCAAGGCTGTAATGGCTGAAAAT
[0055] TCTTACATTTATTTTACATTTTTAGAAATGGGCGTGAAAAAAAGCGCGC
[0056] GATTATGTAAAATATAAAGTGATAGCGGTACCATTATAGGTAAGAGAGG
[0057] AATGTACAC
[0058] SEQ ID NO.3 Phospholipase D gene expression cassette
[0059]
[0060] The upstream homologous arm of the target gene veg of SEQ ID NO.4
[0061] ATTCATGCGCTTGATCCGGTATATATCGTCGCGAAGATCAGCTTTACGCCGTTTATGGAACGGATTAATGTATGGGAAGTGCTCCGTAATACGCTGACAAGAGAGAAAGGGCTTGGAGGTATTGAAACAAGAGGAGTTCTGAGAATTGGTATGCCTTATAAGTCCAATTAACAGTTGAAAACCTGCATAGGAGAGCTATGCGGGTTTTTTATTTTACATAATGATACATAATTTACCGAAACTTGCGGAACATAATTGAGGAATCATAGAATTTTGTCAAAATAATTTTATTGACAACGTCTTATTAACGTTGATATAATTTAAATTTTATTTGACAAAAATGGGCTCGTGTTGTACAATAAATGTAGTGAGGTGGATGCAATGGCGAAGACGTTGTCCGATATTAAAAGATCGCTTGATGGGAATTTAGGTAAAAGGCTGACGTTAAAAGCAAACGGTGGCCGCCGAAAAACGATTGAGCGTTCGGGCATTTTAGCTGAGACGTACCCTTCTGTTTTTGTGATACAACTAGATCAAGACGAGAACTCGTTTGAAAGAGTTTCATACAGTTATGCTGATATTTTGACTGAGACTGTTGAGCTGACATTTAATGATGACGCCGCAAGCTCAGTGGCATTTTAA
[0062] The downstream homologous arm of veg of SEQ ID NO.5
[0063] CGGGCAGTGAACCTTTTGTTTACTGCTTTTTGTTTTGCCCTTTTTTGGTTTCCAATAATTTTAACGAAAGTTCCATCTGATTTAACAAAAGATAAAACAGTCACATATTATCGTGACGTGCACGAATGGCTATCACTTCTAAAAAAGGAGTTGTTTCGTTTGGGCAGACGTCGTGGAGTTATGTCAGATGAGTTTAAATATGAGCTGGCTAAAGACCTTGGTTTTTATGACACAGTAAAAAATGGAGGCTGGGGTGAAATTCGGGCCCGCGATGCCGGTAACATGGTGAAGCGTGCTATTGAAATCGCCGAACAGCAAATGGCTCAGAATCAGAATAACCGATAAGGATGTGACCCGGGGGACGTGCTGTTCCCTGGTTTTTTTATTTTGGATATAAATACATAATGGGCTGAATATGGATATGTTCATCCTGTACTTCAAATGTGATACAATGTTCATACTTATGTTTAGATGGAGAAGTAGGTGAAAGCTATGCGTATTTTAGAAAAAGCGCCAGCTAAGATCAATCTGTCACTTGACGTCACCCGAAAACGCCCGGATGGCTATCATGAAGTCGAAATGATCATGACGACAATTGAT
[0064] Upstream homologous arm of the target gene amyE, SEQ ID NO.6
[0065] GCGGCATTATGTTTGAATTTCCGTTTAAAGAATGGGCTGCAAGCCTTGTGTTTTTGTTCATCATTATCTTATATTACTGCATCAGGGCTGCGGCATCCGGAATGCTCATGCCGAGAATAGACACCAAAGAAGAACTGCAAAAACGGGTGAAGCAGCAGCGAATAGAATCAATTGCGGTCGCCTTTGCGGTAGTGGTGCTTACGATGTACGACAGGGGGATTCCCCATACATTCTTCGCTTGGCTGAAAATGATTCTTCTTTTTATCGTCTGCGGCGGCGTTCTGTTTCTGCTTCGGTATGTGATTGTGAAGCTGGCTTACAGAAGAGCGGTAAAAGAAGAAATAAAAAAGAAATCATCTTTTTTGTTTGGAAAGCGAGGGAAGCGTTCACAGTTTCGGGCAGCTTTTTTTATAGGAACATTGATTTGTATTCACTCTGCCAAGTTGTTTTGATAGAGTGATTGTGATAATTTTAAATGTAAGCGTTAACAAAATTCTCCAGTCTTCACATCGGTTTGAAAGGAGGAAGCGGAAGAATGAAGTAAGAGGGATTTTTGACTCCGAAGTAAGTCTTCAAAAAATCAAATAAGGAGTGTCAAGA
[0066] SEQ ID NO.7 amyE downstream homologous arm
[0067] GGGCAAGGCTAGACGGGACTTACCGAAAGAAACCATCAATGATGGTTTCTTTTTTGTTCATAAATCAGACAAAACTTTTCTCTTGCAAAAGTTTGTGAAGTGTTGCACAATATAAATGTGAAATACTTCACAAACAAAAAGACATCAAAGAGAAACATACCCTGGAAGGATGATTAATGATGAACAAACATGTAAATAAAGTAGCTTTAATCGGAGCGGGTTTTGTTGGAAGCAGTTATGCATTTGCGTTAATTAACCAAGGAATCACAGATGAGCTTGTGGTCATTGATGTAAATAAAGAAAAAGCAATGGGCGATGTGATGGATTTAAACCACGGAAAGGCGTTTGCGCCACAACCGGTCAAAACATCTTACGGAACATATGAAGACTGCAAGGATGCTGATATTGTCTGCATTTGCGCCGGAGCAAACCAAAAACCTGGTGAGACACGCCTTGAATTAGTAGAAAAGAACTTGAAGATTTTCAAAGGCATCGTTAGTGAAGTCATGGCGAGCGGATTTGACGGCATTTTCTTAGTCGCGACAAATCCGGTTGATATCCTGACTTACGCAACATGGAAATTCAGCGGCCTGCCAAAAG
[0068] Upstream homologous arm of target gene zinU, SEQ ID NO.8
[0069] TGGTGACGGTTGTTGATGCCAACCGTTTTTGGCATGATTATCAGTCAGGCGAAAGCCTTCTGGACCGCAAAGAAGCATTGGGGGAAAAGGATGAAAGAGAAATCGCCGACCTCTTGATCGATCAAATTGAGTTTTGCGATGTACTGATCTTAAATAAATGTGATTTGGTCAGCGAGCAAGAGCTCGAACAGCTTGAAAACGTTCTTCGTAAACTGCAGCCAAGAGCCAGGTTCATTCGTTCCGTCAAAGGAAATGTAAAACCGCAGGAGATTTTGCATACAGGGTTATTTAACTTCGAGGAAGCGAGCGGATCGGCCGGCTGGATTCAAGAGCTGACGGCAGGCCATGCGGAACACACCCCGGAAACAGAAGAATACGGTATCTCTTCATTTGTATATAAGAGACGTTTGCCGTTTCATTCTACACGATTTTACCGTTGGTTGGATCAAATGCCAAAGAACGTGGTACGTGCCAAAGGAATCGTCTGGTGCGCATCTCATAACAACCTCGCTTTGCTGATGTCGCAAGCAGGTCCGTCGGTTACGATTGAGCCTGTATCTTATTGGGTGGCGGCGTTGCCGAAGCTTGAGCAGGAGCAAGTCAAACAGCAGGAGCCGGAAATCCTGGAGGAGTGGGACCCGGAGTTCGGCGACCGCCTAACGCAGCTAGTTTTTATCGGAACTGACCTGGATGAAGAAACGATCACGAAAGAGCTTGATCAATGCCTGTTGACTGAGTATGAATTTGATTCCGACTGGTCGCTGTTTGAGGACCCGTTTAAATGGAAGCTGAATCAATAG
[0070] Downstream homologous arm of SEQ ID NO.9 zinU
[0071] AAAAAAAGCCGTCCCATGGGGAACGGCTTTTTTTAATGAAACGTTTGTTTAAACATAATGAGCGTATTTTTTCTCAAGGATATTCTGAAAGACCGCGGCAATGGAGCAGATGGCCCAATAAATGAGAGCGGTCAGAATATACATGGTCATATAATCAAACTCTCTGCCCCCGATGATTTTCGCATGCTGGAGCAATTCCGGCACTGTAATCATCGCAGCGAGAGAGGACGCCTTGATCAAGTCGAGCAATACATTGGCAAGCGGAGGCAGCGCAATACGTATCGATTGCGGCAAAATGATGCCCCTCATCGTCTGCCAATAGGAAAGACCCAGCGAGGATGCGGCTTCCCACTGTCCTTTTTCGACGGATGAAATGGCTGAACGGTTAATTTCCGCAATGTAGGCGGCGCTGTTTAGGCTAAAGCCGATTAAAGCAGCCGTGACAGCGGAAAATTCAATGCCGATATAAGGAAACCCGAAATAAAGGATAAACAAAATCACCAAAATCGGAACGCCTCGCATAAATGAGATATAGAGCTTCGCCGGCCATCTTAACAAAGCAAGTTTAGACATTCTGGCGAGTGATATGAACAGGCCGATCACAGTTCCCGCAAACATGCTTACAAAAGAGATGAGCAGTGTATAACCAATGCCTTTTATGACATAAGGGAACGATTCAATGGCCAGCTTCGTGTTGAAAATATATTCCCACTGAATGCTATTGATCATGGCGTCCGATTACAAATCAACGTCCTGAACGTCGGCATCAATTTTTTTTGATACATCTGCTTTATTGAAGA
[0072] The nucleotide sequence of the recombinant plasmid pPLDsan31 with SEQ ID NO.10 using plasmid pMA5 as the expression vector
[0073]
[0074] SEQ ID NO.11 Phospholipase D amino acid sequence
[0075] MTSDQRPARLPTHKGKLLAPHRLHRLIPVSVALTVCAALPSSTAYAADTPPTPHLDAIERSLRDTSPGLEGSVWQRTDGNRLDAPDGDPAGWLLQTPGCWGDAGCKDRAGTRRLLDKMTRNIADARHTVDISSLAPFP NGGFEDAVVDGLKAVVAAGHSPRVRILVGAAPIYHLNVVPSRYRDELIGKLGAAAGKVTLNVASMTTSKTSLSWNHSKLLVVDGKTAITGGINGWKDDYLDTAHPVSDVDMALSGPAAASAGKYLDTLWDWTCRNASDP AKVWLATSNGASCMPSMEQDEAGSAPAEPTGDVPVIAVGGLGVGIKESDPSSGYHPDLPTAPDTKCTVGLHDNTNADRDYDTVNPEENALRSLIASARSHVEISQQDLNATCPPLPRYDIRTYDTLAGKLAAGVKVRIV VSDPANRGAVGSGGYSQIKSLDEISDTLRTRLVALTGDNEKASRALCGNLQLASFRSSDAAKWADGKPYALHHKLVSVDDSAFYIGSKNLYPAWLQDFGYIVESPAAAQQLKTELLDPEWKYSQQAAATPAGCPARQAG
[0076] Embodiment 1:
[0077] The present invention provides a phospholipase D comprising 556 amino acids, and the amino acid sequence is shown in SEQ ID NO.11.
[0078] The present invention also provides a free-type plasmid for expressing phospholipase D, named pPLDsan31, comprising a phospholipase D sequence, a signal peptide penP for expressing phospholipase D extracellularly, and a promoter P43 for expressing phospholipase D, wherein the nucleotide sequence of the signal peptide penP is shown in SEQ ID NO.1, has a total length of 108 nucleotides, and encodes 36 amino acids; the nucleotide sequence of the promoter P43 is shown in SEQ ID NO.2, has a total length of 281 nucleotides.
[0079] Embodiment 2:
[0080] This example provides a method for constructing a recombinant strain BS-pPLDsan, and the specific steps are as follows:
[0081] (1) Amplification of phospholipase D coding sequence
[0082] Using the recombinant plasmid pET-28a(+)-PLDsan containing the phospholipase D encoding gene as a template, primers (P1, P2) were designed to amplify the phospholipase D encoding sequence:
[0083] Primer P1: 5'-CCTAAAAAGGAGCGATTTACATATGATGACCAGTGATCAGCGTC-3'
[0084] Primer P2: 5′-GCTTGAGCTCGACTCTAGAGGATCCTTAACCTGCCTGT CTTGCAG-3′
[0085] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 1min, a total of 33 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0086] (2) Linearization of pMA5 plasmid
[0087] The pMA5 plasmid was digested with Nde I and then subjected to nucleic acid electrophoresis verification at 37°C for 3 h and the linearized plasmid was recovered by gel cutting.
[0088] (3) Construction of linear DNA polymers
[0089] Add 0.2 pmol of each of the products recovered in steps (1) and (2) to a PCR tube and add an equal volume of The connection was carried out by POE-PCR reaction. The reaction conditions were as follows: pre-denaturation at 95°C for 30 seconds followed by cycling: denaturation at 95°C for 15 seconds, annealing at 55°C for 15 seconds, extension at 72°C for 7 minutes, for a total of 30 cycles; and final extension at 72°C for 5 minutes.
[0090] (4) Linear DNA polymer transformation of Bacillus subtilis WB600
[0091] The linear DNA polymer in step (3) was transformed into Bacillus subtilis WB600. The positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company, and the recombinant strain with the correct sequence was named BS-pPLDsan, and the plasmid pPLDsan was extracted. The recombinant strain was cultured in TB medium for 36 hours. The fermentation broth was centrifuged at 12000 rpm for 10 minutes at 4°C, and the supernatant was collected for activity determination. The enzyme activity of the recombinant strain BS-pPLDsan was 93.4U / mL.
[0092] Embodiment 3:
[0093] This example provides a method for constructing a signal peptide and promoter-modified episomal plasmid pPLDsan31 and expressing it in Bacillus subtilis. The specific steps are as follows:
[0094] (1) Using the Bacillus subtilis 168 genome as a template, primers (P3, P4) were designed to amplify the penP signal peptide sequence, and primers (P5, P6) were designed to amplify the P43 promoter sequence:
[0095] Primer P3: 5′-ATGAAGTTGAAAACTAAAGCGTC-3′
[0096] Primer P4: 5'-GTGCCGGACGCTGATCACTGGTCATTGCTTCGGCATGT GTTGAG-3'
[0097] Primer P5: 5′-CCTAAAAAGGAGCGATTTACATATGCGGTTGATTTAAT AACTGACAAAC-3′
[0098] Primer P6: 5′-GACGCTTTAGTTTTCAACTTCATTCCTCTCTTACCTAT AA-3′
[0099] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 30s, a total of 33 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0100] (2) Linearization of pPLDsan plasmid
[0101] The pPLDsan plasmid in Example 2 was digested with Nde I, and then digested at 37° C. for 3 h, and then nucleic acid electrophoresis was performed to verify and the linearized plasmid was recovered by gel tapping.
[0102] (3) Construction of linear DNA polymers
[0103] Add 0.2 pmol of each of the products recovered in steps (1) and (2) to a PCR tube and add an equal volume of The connection was carried out by POE-PCR reaction. The reaction conditions were as follows: pre-denaturation at 95°C for 30 seconds followed by cycling: denaturation at 95°C for 15 seconds, annealing at 55°C for 15 seconds, extension at 72°C for 7 minutes, for a total of 30 cycles; and final extension at 72°C for 5 minutes.
[0104] (4) Linear DNA polymer transformation of Bacillus subtilis WB600
[0105] The linear DNA polymer in step (3) was transformed into Bacillus subtilis WB600. The positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company, and the recombinant strain with the correct sequence was named BS-pPLDsan31. The plasmid pPLDsan31 was extracted. The obtained plasmid pPLDsan31 contained a phospholipase D gene expression cassette. The nucleotide sequence of the phospholipase D gene expression cassette was shown in SEQ ID NO.3, and the nucleotide sequence of the plasmid pPLDsan31 was shown in SEQ ID NO.10. The recombinant strain was cultured in TB medium for 36 hours. The fermentation broth was centrifuged at 12000 rpm for 10 minutes at 4°C, and the supernatant was collected for activity determination. The enzyme activity of the recombinant strain BS-pPLDsan31 was 815.9 U / mL, which was 8.7 times higher than that of the unmodified strain.
[0106] Embodiment 4:
[0107] This example provides a method for constructing an integrated expression strain BS-PLD1, and the specific steps are as follows:
[0108] (1) Using the plasmid pPLDsan31 constructed in Example 3 as a template, primers (P7, P8) were designed to amplify the phospholipase D gene expression cassette sequence:
[0109] Primer P7: 5′-GATCTTCTCAAAAAATACTACCTGTC-3′
[0110] Primer P8: 5′-CGTTGAAAATCTCCAAAAAAAAAG-3′
[0111] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 1min, a total of 30 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0112] (2) Using the Bacillus. subtilis 168 genome as a template, primers (P9, P10) were designed to amplify the upstream homology arm of veg, and primers (P11, P12) were designed to amplify the downstream homology arm of veg:
[0113] Primer P9: 5′-CGACTCACTATAGGGTCGACGGCCACCTGTATTAAAAA CACGGTCAG-3′
[0114] Primer P10: 5′-ACAGGTAGTATTTTTTGAGAAGATCCGTCAAGAACAT CGAAGTTGCGAG-3′
[0115] Primer P11: 5′-CCTTTTTTTTTGGAGATTTTCAACGCCTGTATTAAAAACCGGTCAG-3′
[0116] Primer P12: 5′-GATGAAGATTATTTCTTAATCTAGACGTCAAGAACATC GAAGTTGC-3′
[0117] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 30s, a total of 30 cycles; 72℃ final extension for 5min. The PCR product was identified by nucleic acid electrophoresis and purified by gel cutting. The obtained veg upstream homology arm nucleotide sequence is shown in SEQ ID NO.4, and the veg downstream homology arm nucleotide sequence is shown in SEQ ID NO.5.
[0118] (3) Using plasmid pJOE8999 as a template, primers (P13, P14) were designed to amplify the sgRNA sequence
[0119] Primer P13: 5′-TGGCCGTCGACCCTATAG-3′
[0120] Primer P14: 5′-GAGAATTGAGTAAAATGTACCTACGTTAAAATGCCACTGAGCTTGGTTTTAGAGCTAGAAATAGCAAG-3′
[0121] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 30s, 55℃ annealing for 30s, 72℃ extension for 10s, a total of 30 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0122] (4) Linearization of pJOE8999 plasmid
[0123] The pJOE8999 plasmid was double-digested with Bsa I and Xba I at the same time. After digestion at 37°C for 3 h, nucleic acid electrophoresis was performed to verify and the linearized plasmid was recovered by gel cutting.
[0124] (5) Construction of gene editing plasmid pJOE8999-PLD1:
[0125] Add 0.02 pmol of each of the products recovered from step (1), (2), and (3) and 0.06 pmol of the linearized plasmid from step (4) to the PCR tube, and add an equal volume of Hieff Universal Enzyme Premix. After mixing, ligate at 50℃ for 30min, transform the ligation product into E.coli JM 109 competent cells, culture overnight on solid LB medium containing kanamycin resistance (50mg / L), and pick multiple transformants into LB liquid medium (Kanamycin resistant (50mg / L)). r ), cultured at 37°C, 220rpm for 10-12h, extracted the plasmid, performed PCR verification and sent it to Tianlin Sequencing Company for sequence determination, and the plasmid with the correct sequence was named pJOE8999-PLD1.
[0126] (6) Construction of integrated expression strain BS-PLD1
[0127] The plasmid pJOE8999-PLD1 was transformed into Bacillus.subtilis WB600 competent cells, and the positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company. The integrated strain with the correct sequence was named BS-PLD1. The integrated strain BS-PLD1 was cultured in TB medium for 24 hours. The fermentation broth was centrifuged at 12000 rpm for 10 minutes at 4°C, and the supernatant was collected for activity determination. The enzyme activity of the integrated strain BS-PLD1 was 56.4U / mL.
[0128] Embodiment 5:
[0129] This example provides a method for constructing the integrated strain BS-PLD2, and the specific steps are as follows:
[0130] (1) Using the plasmid pPLDsan31 constructed in Example 3 as a template, primers (P7, P8) were designed to amplify the phospholipase D sequence:
[0131] Primer P7: 5′-GATCTTCTCAAAAAATACTACCTGTC-3′
[0132] Primer P8: 5′-CGTTGAAAATCTCCAAAAAAAAAG-3′
[0133] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 1min, a total of 30 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0134] (2) Using the Bacillus subtilis 168 genome as a template, primers (P15, P16) were designed to amplify the upstream homology arm of amyE, and primers (P17, P18) were designed to amplify the downstream homology arm of amyE:
[0135] Primer P15: 5′-CGACTCACTATAGGGTCGACGGCCAGCGGCATTATGT TTGAATTTCC-3′
[0136] Primer P16: 5′-ACAGGTAGTATTTTTTGAGAAGATCTCTTGACACTCCT TATTTGATT-3′
[0137] Primer P17: 5'-CCTTTTTTTTTGGAGATTTTCAACGGGGCAAGGCTAG ACGG-3'
[0138] Primer P18: 5′-GATGAAGATTATTTCTTAATCTAGACTTTTGGCAGGCC GCTGAATTTC-3′
[0139] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 30s, a total of 30 cycles; 72℃ final extension for 5min. The PCR product was identified by nucleic acid electrophoresis and purified by gel cutting. The obtained amyE upstream homology arm nucleotide sequence is shown in SEQ ID NO.6, and the amyE downstream homology arm nucleotide sequence is shown in SEQ ID NO.7.
[0140] (3) Using plasmid pJOE8999 as a template, primers (P13, P19) were designed to amplify the sgRNA sequence. Primer P13: 5'-TGGCCGTCGACCCTATAG-3'
[0141] Primer P19: 5′-GAGAATTGAGTAAAATGTACCTACGCGCGTCAAACAGCTGCACGGGTTTTAGAGCTAGAAATAGCAAG-3′
[0142] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 30s, 55℃ annealing for 30s, 72℃ extension for 10s, a total of 30 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0143] (4) Linearization of pJOE8999 plasmid
[0144] The pJOE8999 plasmid was double-digested with Bsa I and Xba I at the same time. After digestion at 37°C for 3 h, nucleic acid electrophoresis was performed to verify and the linearized plasmid was recovered by gel cutting.
[0145] (5) Construction of gene editing plasmid pJOE8999-PLD2:
[0146] Add 0.02 pmol of each of the products recovered from step (1), (2), and (3) and 0.06 pmol of the linearized plasmid from step (4) to the PCR tube, and add an equal volume of Hieff Universal Enzyme Premix. After mixing, ligate at 50℃ for 30min, transform the ligation product into E.coli JM 109 competent cells, culture overnight on solid LB medium containing kanamycin resistance (50mg / L), and pick multiple transformants into LB liquid medium (Kanamycin resistant (50mg / L)). r), cultured at 37°C and 220 rpm for 10-12 h, extracted the plasmid, performed PCR verification and sent it to Tianlin Sequencing Company for sequence determination, and the plasmid with the correct sequence was named pJOE8999-PLD2.
[0147] (6) Construction of integrated strain BS-PLD2
[0148] The plasmid pJOE8999-PLD2 was transformed into Bacillus.subtilis WB600 competent cells, and the positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company. The integrated strain with the correct sequence was named BS-PLD2. The integrated strain BS-PLD2 was cultured in TB medium for 24 hours. The fermentation broth was centrifuged at 12000 rpm for 10 minutes at 4°C, and the supernatant was collected for activity determination. The enzyme activity of the integrated strain BS-PLD2 was 52.3U / mL.
[0149] Embodiment 6:
[0150] This example provides a method for constructing the integrated strain BS-PLD3, and the specific steps are as follows:
[0151] (1) Using the plasmid pPLDsan31 constructed in Example 3 as a template, primers (P7, P8) were designed to amplify the phospholipase D sequence:
[0152] Primer P7: 5′-GATCTTCTCAAAAAATACTACCTGTC-3′
[0153] Primer P8: 5′-CGTTGAAAATCTCCAAAAAAAAAG-3′
[0154] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 1min, a total of 30 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0155] (2) Using the Bacillus subtilis 168 genome as a template, primers (P20, P21) were designed to amplify the upstream homology arm of zinU, and primers (P22, P23) were designed to amplify the downstream homology arm of zinU:
[0156] Primer P20: 5'-CGACTCACTATAGGGTCGACGGCCATGGTGACGTTG TTGATG-3'
[0157] Primer P21: 5′-ACAGGTAGTATTTTTTGAGAAGATCCTATTGATTCA GCTTCCATTTAAAC-3′
[0158] Primer P22: 5′-CCTTTTTTTTTGGAGATTTTCAACGAAAAAAAGCCGT CCCATG-3′
[0159] Primer P23: 5′-GATGAAGATTATTTCTTAATCTAGATCTTCAATAAAGC AGATGTATC-3′
[0160] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions were: 95℃ pre-denaturation for 3min, followed by cycling: 95℃ denaturation for 15s, 55℃ annealing for 15s, 72℃ extension for 30s, 30 cycles in total; 72℃ final extension for 5min. The PCR products were identified by nucleic acid electrophoresis and purified by gel cutting. The obtained zinU upstream homology arm nucleotide sequence is shown in SEQ ID NO.8, and the zinU downstream homology arm nucleotide sequence is shown in SEQ ID NO.9.
[0161] (3) Using plasmid pJOE8999 as a template, primers (P13, P24) were designed to amplify the sgRNA sequence. Primer P13: 5'-TGGCCGTCGACCCTATAG-3'
[0162] Primer P24: 5′-GAGAATTGAGTAAAATGTACCTACGGATGGCCCAATAAATGAGAGGTTTTAGAGCTAGAAATAGCAAG-3′
[0163] The PCR amplification reaction was carried out in a 40 μL system, and 20 μL was added to the reaction system. 17μL ddH2O, 1μL template DNA, 1μL upstream and downstream primers. The reaction conditions are: 95℃ pre-denaturation for 3min, then start the cycle: 95℃ denaturation for 30s, 55℃ annealing for 30s, 72℃ extension for 10s, a total of 30 cycles; 72℃ final extension for 5min. PCR products were identified by nucleic acid electrophoresis and purified by gel cutting.
[0164] (4) Linearization of pJOE8999 plasmid
[0165] The pJOE8999 plasmid was double-digested with Bsa I and Xba I at the same time. After digestion at 37°C for 3 h, nucleic acid electrophoresis was performed to verify and the linearized plasmid was recovered by gel cutting.
[0166] (5) Construction of gene editing plasmid pJOE8999-PLD3:
[0167] Add 0.02 pmol of each of the products recovered from step (1), (2), and (3) and 0.06 pmol of the linearized plasmid from step (4) to the PCR tube, and add an equal volume of Hieff Universal Enzyme Premix. After mixing, ligate at 50℃ for 30min, transform the ligation product into E.coli JM 109 competent cells, culture overnight on solid LB medium containing kanamycin resistance (50mg / L), and pick multiple transformants into LB liquid medium (Kanamycin resistant (50mg / L)). r ), cultured at 37°C and 220 rpm for 10-12 h, extracted the plasmid, performed PCR verification and sent it to Tianlin Sequencing Company for sequence determination, and the plasmid with the correct sequence was named pJOE8999-PLD3.
[0168] (6) Construction of integrated strain BS-PLD3
[0169] Plasmid pJOE8999-PLD3 was transformed into Bacillus.subtilis WB600 competent cells, and positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company. The integrated strain with the correct sequence was named BS-PLD3. The integrated strain BS-PLD3 was cultured in TB medium for 24 hours. The fermentation broth was centrifuged at 12000rpm for 10 minutes at 4°C, and the supernatant was collected for activity determination. The enzyme activity of the integrated strain BS-PLD3 was 65.0U / mL.
[0170] Embodiment 7:
[0171] This example provides a method for constructing multi-copy integrated strains BS-PLD31 and BS-PLD312, and the specific steps are as follows:
[0172] The plasmid pJOE8999-PLD1 in Example 4 was transformed into the competent cells of the integrated strain BS-PLD3 in Example 6, and the positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company, and the integrated strain with the correct sequence was named BS-PLD31; the plasmid pJOE8999-PLD2 in Example 5 was transformed into the competent cells of the integrated strain BS-PLD31, and the positive transformants were determined by colony PCR and sequence determination by Tianlin Sequencing Company, and the integrated strain with the correct sequence was named BS-PLD312. The integrated strains BS-PLD31 and BS-PLD312 were cultured in TB medium for 24 hours. The fermentation broth was centrifuged at 12000rpm for 10 minutes at 4°C, and the supernatant was collected for enzyme activity determination. The enzyme activity of the integrated strain BS-PLD31 was 125.8U / mL, and the enzyme activity of the integrated strain BS-PLD312 was 151.8U / mL.
[0173] Embodiment 8:
[0174] This example provides a high-density fermentation method on a 7-L tank of the recombinant strain BS-pPLDsan31 and the integrated strain BS-PLD312, and the specific steps are as follows:
[0175] The recombinant strain BS-pPLDsan31 in Example 3 was inoculated into TB liquid culture medium (Kan r ) and cultured at 37°C and 220rpm until the logarithmic growth phase as seed liquid; then the seed liquid was transferred to 7L fermentation medium (15g / L glycerol, 12g / L peptone, 24g / L soybean cake powder, 2.31g / L potassium dihydrogen phosphate, 16.42g / L potassium dihydrogen phosphate trihydrate) containing 50mg / mL kanamycin at an inoculum of 5%, and the pH was controlled to 7-7.5 with ammonia water and acetic acid, the culture temperature was 37°C, and the dissolved oxygen was controlled at about 20%. After about 12h of culture, feed medium (75g / L glycerol, 60g / L peptone, 120g / L soybean cake powder, 2.31g / L potassium dihydrogen phosphate, 16.42g / L potassium dihydrogen phosphate trihydrate, flow rate 38.57mL / h) was controlled according to dissolved oxygen (20%), and samples were taken every 6h to measure enzyme activity. At 78h, the enzyme activity of the recombinant strain BS-pPLDsan31 increased to 4055.9U / mL, which was nearly 4.0 times higher than that of the shake flask culture ( Figure 5 ).
[0176] The recombinant strain BS-PLD312 in Example 7 was inoculated into TB liquid medium and cultured at 37°C and 220rpm until the logarithmic growth phase as seed liquid; the seed liquid was then transferred to 7L fermentation medium (15g / L glycerol, 12g / L peptone, 24g / L soybean cake powder, 2.31g / L potassium dihydrogen phosphate, 16.42g / L dipotassium hydrogen phosphate trihydrate) at an inoculum of 5%, the pH was controlled to 7-7.5 with ammonia water and acetic acid, the culture temperature was 37°C, and the dissolved oxygen was controlled at about 20%. After about 12h of culture, feed medium (75g / L glycerol, 60g / L peptone, 120g / L soybean cake powder, 2.31g / L potassium dihydrogen phosphate, 16.42g / L dipotassium hydrogen phosphate trihydrate, flow rate 38.57mL / h) was controlled according to dissolved oxygen (20%), and enzyme activity was measured every 6h. The enzyme activity of the integrated strain BS-PLD312 reached the highest level at 42h, with an enzyme activity of 392.9U / mL ( Figure 6 ).
[0177] Embodiment 9:
[0178] This embodiment provides a method for preparing phosphatidic acid (PA).
[0179] The initial transformation conditions adopted were: the fermentation supernatant obtained by fermenting the recombinant strain BS-pPLDsan31 was diluted with PBS solution to obtain a crude enzyme solution with an enzyme activity of 200 U / ml, 50 g / L soybean lecithin was fully dispersed in 10 mL of the crude enzyme solution, and the reaction was oscillated at 40°C and 1000 rpm for 10 hours.
[0180] 20 mL of chloroform-methanol (volume ratio 10:1) mixed solution was added to the above reaction solution to extract the reaction solution three times. The organic phases were combined and concentrated by vacuum centrifugal concentrator to remove the organic phase, and 20 mL of n-hexane-isopropanol (volume ratio 1:1) was added to dissolve, and after filtering through a 0.22 μm organic membrane, the product phosphatidic acid was detected and analyzed by HPLC.
[0181] In order to obtain the best conversion rate, the conversion conditions were optimized in this example. The conversion process was optimized from three perspectives: the amount of substrate soybean lecithin, reaction temperature, and reaction time, and compared with the commonly used two-phase system. At the same time, the ability of the integrated strain BS-PLD312 to produce phosphatidic acid was tested.
[0182] (1) Dosage of substrate soybean lecithin
[0183] 50, 100, 150, 200, 250, and 300 g / L of soybean lecithin were added for phospholipase D catalytic reaction. According to HPLC analysis, when the substrate concentration was lower than 200 g / L, the conversion rate remained basically unchanged, stabilizing at about 90%. After the substrate concentration continued to increase, the conversion rate began to decrease. When the substrate concentration was 200 g / L, the PA yield reached 181.3 g / L, and when the substrate concentration was 300 g / L, the PA yield reached the highest, 219.1 g / L.
[0184] (2) Reaction temperature
[0185] 200g / L soybean lecithin was used at 25, 30, 35, 40, 45, 50, 55°C, and other reaction conditions were kept unchanged to investigate the effect of different conversion temperatures on the conversion rate. The HPLC test results show that the best conversion temperature is 40°C, with a conversion rate of 90.7%, so 40°C can be used as the optimal conversion temperature.
[0186] (3) Response time
[0187] The reaction time in the optimized conditions of step 2 was adjusted to 1, 2, 3, 4, 5, 6, 7, 8, and 10 h to investigate the effect of different conversion times on the conversion rate. The HPLC test results showed that the best conversion time was 6 h, with a conversion rate of 90.7% and a space-time yield of 30.2 g / L / h, so the conversion time of 6 h can be used as the optimal conversion time.
[0188] (4) Differences from the two-phase system
[0189] The conditions after step 3 optimization were used and compared with several common two-phase systems (butyl acetate-water, toluene-water, methoxycyclopentane-water, ethyl acetate-water, n-hexane-water, volume ratio 1:1, reaction time 12h, other treatment conditions unchanged). The HPLC test results show that the PA yields of the five two-phase systems are 130.9, 76.1, 153.6, 134.8, and 23.3 g / L, respectively. Compared with the two-phase system, the aqueous reaction system has a high conversion rate and a significantly higher catalytic efficiency than the two-phase reaction system. In addition, the aqueous reaction system greatly reduces the use of organic solvents, shortens the reaction time, improves production efficiency, and has obvious potential for industrial application.
[0190] (5) Test of the ability of integrated strain BS-PLD312 to produce phosphatidic acid
[0191] The fermentation supernatant obtained by fermentation of the integrated strain BS-PLD312 was diluted with PBS solution to obtain a crude enzyme solution with an enzyme activity of 200U / ml. 200g / L soybean lecithin was fully dispersed in 10mL of the crude enzyme solution and oscillated for 6h at 40°C and 1000rpm. 20mL of chloroform-methanol (volume ratio 10:1) mixed solution was added to the above reaction solution to extract the reaction solution three times. The organic phases were combined and concentrated by a vacuum centrifugal concentrator to remove the organic phase, and 20mL of n-hexane-isopropanol (volume ratio 1:1) was added to dissolve, and after filtering through a 0.22μm organic membrane, HPLC was used to detect and analyze the product phosphatidic acid. The HPLC test results showed that the conversion rate was 89.7% and the time-space yield was 29.9g / L / h.
[0192] The above-described embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope of the present invention is not limited thereto. Equivalent substitutions or changes made by those skilled in the art based on the present invention are within the protection scope of the present invention. The protection scope of the present invention shall be subject to the claims.
Claims
1. A phospholipase D gene expression cassette, characterized in that: The phospholipase D gene expression box comprises a signal peptide penP coding sequence, a promoter P43 coding sequence and a phospholipase D gene coding sequence regulated by the signal peptide penP and the promoter P43.
2. The phospholipase D gene expression cassette according to claim 1, characterized in that The nucleotide sequence of the signal peptide penP is shown in SEQ ID NO.1, the nucleotide sequence of the promoter P43 is shown in SEQ ID NO.2, and the amino acid sequence of the phospholipase D is shown in SEQ ID NO.
11.
3. A free plasmid expressing phospholipase D, characterized in that: The episomal plasmid comprises the phospholipase D gene expression cassette according to claim 1 or 2.
4. A recombinant strain expressing phospholipase D in a free manner, characterized in that: The recombinant strain uses Bacillus subtilis as a host, and the episomal plasmid according to claim 3 is introduced into the host.
5. The recombinant strain according to claim 4, characterized in that The host includes Bacillus subtilis WB600.
6. An integrated strain for expression of phospholipase D, characterized in that: The integration strain uses Bacillus subtilis as a host, and the phospholipase D gene expression cassette according to claim 1 or 2 is integrated into the host genome.
7. The integrated strain according to claim 6, characterized in that The gene sites integrated into the host genome include one or more of veg, amyE and zinU genes.
8. The integrated strain according to claim 6, characterized in that The host includes Bacillus subtilis WB600.
9. Use of the recombinant strain according to claim 4 or 5 or the integrated strain according to any one of claims 6 to 8 in producing phospholipase D.
10. Use of the recombinant strain according to claim 4 or 5 or the integrated strain according to any one of claims 6 to 8 in producing phosphatidic acid.
